Drug Shortage Report for XANAX
| Report ID | 162663 |
| Drug Identification Number | 00723770 |
| Brand name | XANAX |
| Common or Proper name | Xanax |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALPRAZOLAM |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | BTL 100 |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-04-04 |
| Estimated end date | Unknown |
| Actual end date | 2023-01-20 |
| Shortage status | Resolved |
| Updated date | 2023-02-14 |
| Company comments | Xanax 0.25mg & 0.5mg will remain available during this period. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2023-02-14 | French | Compare |
| v14 | 2023-02-14 | English | Compare |
| v13 | 2023-01-17 | French | Compare |
| v12 | 2023-01-17 | English | Compare |
| v11 | 2022-11-29 | French | Compare |
| v10 | 2022-11-29 | English | Compare |
| v9 | 2022-09-01 | French | Compare |
| v8 | 2022-09-01 | English | Compare |
| v7 | 2022-08-01 | French | Compare |
| v6 | 2022-08-01 | English | Compare |
| v5 | 2022-07-04 | French | Compare |
| v4 | 2022-07-04 | English | Compare |
| v3 | 2022-06-16 | English | Compare |
| v2 | 2022-06-15 | French | Compare |
| v1 | 2022-06-15 | English | Compare |
Showing 1 to 15 of 15